Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides

Rheumatology

Volumn 47, Issue 5, 2008, Pages 597-604

  Tilleman, K ^a   Van Steendam, K ^a   Cantaert, T ^b   De Keyser, F ^b   Elewaut, D ^b   Deforce, Dieter ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Autoantibodies; Citrullinated vimentin; Human; Inflammation; Rheumatoid arthritis

Indexed keywords

AMINO ACID; AUTOANTIBODY; CASPASE 3; ISOPROTEIN; POLYCLONAL ANTIBODY; VIMENTIN;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME DEGRADATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN CITRULLINATION; PROTEIN MODIFICATION; RHEUMATOID ARTHRITIS; SEROLOGY; SPONDYLOARTHROPATHY; SYNOVIUM; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AGED; ANTIGEN-ANTIBODY REACTIONS; ARTHRITIS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; CASPASE 3; CITRULLINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; PROTEIN ISOFORMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPONDYLITIS, ANKYLOSING; SYNOVIAL MEMBRANE; VIMENTIN;

EID: 42949148588     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken077     Document Type: Article

References (38)

1. Tamer IH, Harle P, Muller-Ladner U, Gay RE, Gay S. The different stages of synovitis: Acute vs chronic, early vs late and non-erosive vs erosive. Best Pract Res Clin Rheumatol 2005;19:19-35.
2. Baeten D, Dernetter P, Cuvelier C et al. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: Influence of disease duration and activity. Ann Rheum Dis 2000;59:945-53.
3. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: Specificity, sensitivity and diagnostic value. Arthritis Res 2002;4:87-93.
4. Despres N, Boire G, Lopez-Longo FJ, Menard HA. The Sa system: A novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol 1994;21:1027-33.
5. Vossenaar ER, Despres N, Lapointe E et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004;6:R142-50.
6. Osung OA, Chandra M, Holborow EJ. Intermediate filaments in synovial lining cells in rheumatoid arthritis and other arthritides are of vimentin type. Ann Rheum Dis 1982;41:74-7.
7. Fuchs E, Weber K. Intermediate filaments: Structure, dynamics, function, and disease. Annu Rev Biochem 1994;63:345-82.
8. Martys JL, Ho CL, Liem RK, Gundersen GG. Intermediate filaments in motion: Observations of intermediate filaments in cells using green fluorescent protein-vimentin. Mol Biol Cell 1999;10:1289-95.
9. Eriksson JE, He T, Trejo-Skalli AV et al. Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J Cell Sci 2004;117:919-32.
10. Eckes B, Colucci-Guyon E, Smola H et al. Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci 2000;113:2455-62.
11. Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM. Vimentin is secreted by activated macrophages. Nat Cell Biol 2003;5:59-63.
12. Moisan E, Girard D. Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J Leukoc Biol 2006;79:489-98.
13. Vossenaar ER, Radstake TR, van der Heijden A et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004;63:373-81.
14. Baeten D, Van den Bosch F, Elewaut D, Stuer A, Veys EM, De Keyser F. Needle arthroscopy of the knee with synovial biopsy sampling: Technical experience in 150 patients. Clin Rheumatol 1999;18:434-41.
15. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Dougados M, van der Linden S, Juhlin R et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
17. Altman R, Asch E, Bloch D et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49.
18. Tilleman K, Van Beneden K, Dhondt A et al. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry. Proteomics 2005;5:2247-57.
19. Fujita J, Bandoh S, Yang Y et al. High molecular weight vimentin complex is formed after proteolytic digestion of vimentin by caspase-3: detection by sera of patients with interstitial pneumonia. Microbiol Immunol 2003;47:447-51.
20. Byun Y, Chen F, Chang R, Trivedi M, Green KJ, Cryns VL. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ 2001;8:443-50.
21. van Venrooij WJ, Prulin GJ. Citrullination: A small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2000;2:249-51.
22. Inagaki M, Takahara H, Nishi Y, Sugawara K, Sato C. Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J Biol Chem 1989;264:18119-27.
23. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001;166:4177-84.
24. Chapuy-Regaud S, Sebbag M, Baeten D et al. Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. J Immunol 2005;174:5057-64.
25. Chang X, Yamada R, Suzuki A et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology 2005;44:40-50.
26. Chang X, Han J. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol Carcinog 2006;45:183-96.
27. Asaga H, Yamada M, Senshu T. Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun 1998;243:641-6.
28. Egerer K, Bang H, Lathke K et al. A new powerful marker for the diagnosis and prognosis of rheumatoid arthritis - anti-CVM (anti-citrullinated vimentin mutated) antibodies. Arthritis Rheum 2005;52:S118.
29. Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther 2006;8:R119.
30. Soos L, Szekanecz Z, Szabo Z et al. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. J Rheumatol 2007;34:1658-63.
31. Bang H, Egerer K, Gauliard A et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 2007;56:2503-11.
32. Boire G, Cossette P, de Brum-Fernandes AJ et al. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Arthritis Res Ther 2005;7: R592-603.
33. Vincent C, de Keyser F, Masson-Bessiere C, Sebbag M, Veys EM, Serre G. Antiperinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis 1999;58:42-8.
34. Vincent C, Nogueira L, Sebbag M et al. Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: A highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum 2002;46:2051-8.
35. Goldbach-Mansky R, Lee J, McCoy A et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236-43.
36. Kroot EJ, de Jong BA, van Leeuwen MA et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:1831-5.
37. Hammer J, Gallazzi F, Bono E et al. Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association. J Exp Med 1995;181: 1847-55.
38. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003;171:538-41.